0,946  0,004  Apoptosis agonist
0,915  0,005  Transcription factor NF kappa B inhibitor
0,914  0,005  Antiinflammatory
0,878  0,004  Antineoplastic (melanoma)
0,873  0,004  Caspase 9 stimulant
0,870  0,005  Antineoplastic (lung cancer)
0,854  0,004  Chemopreventive
0,847  0,005  Antineoplastic (breast cancer)
0,829  0,004  Nitric oxide antagonist
0,820  0,005  Prostate cancer treatment
0,813  0,005  Chemoprotective
0,791  0,005  Antineoplastic (ovarian cancer)
0,786  0,004  Hepatic disorders treatment
0,780  0,001  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,775  0,003  Hepatoprotectant
0,769  0,004  Antineoplastic (pancreatic cancer)
0,768  0,009  Cyclophilin D inhibitor
0,768  0,009  Antidiabetic
0,762  0,004  Hypoxia-inducible factor 1 alpha inhibitor
0,749  0,005  Antineoplastic (cervical cancer)
0,746  0,005  5 Hydroxytryptamine release stimulant
0,746  0,009  Antileukemic
0,726  0,002  Phosphorylase inhibitor
0,735  0,012  Antineoplastic (colorectal cancer)
0,728  0,011  Antineoplastic (colon cancer)
0,708  0,003  Phospholipase C inhibitor
0,697  0,003  Antineoplastic (endocrine cancer)
0,674  0,001  Interferon gamma antagonist
0,670  0,003  ICAM1 expression inhibitor
0,672  0,005  Antineoplastic (multiple myeloma)
0,667  0,003  Protein-tyrosine phosphatase 1B inhibitor
0,658  0,005  UGT1A4 substrate
0,657  0,018  TNF expression inhibitor
0,646  0,008  Caspase 3 stimulant
0,643  0,006  Antineoplastic (glioma)
0,638  0,006  Apoptosis antagonist
0,635  0,004  Protein-tyrosine phosphatase inhibitor
0,655  0,042  Alpha-glucosidase inhibitor
0,584  0,010  Antidiabetic (type 2)
0,574  0,003  AMP-activated protein kinase stimulant
0,591  0,020  Cholesterol antagonist
0,579  0,009  Hypoglycemic
0,574  0,007  Vascular (periferal) disease treatment
0,576  0,013  AR expression inhibitor
0,580  0,018  Antihypercholesterolemic
0,574  0,013  Antioxidant
0,549  0,004  Antiviral (Influenza A)
0,552  0,008  Antineoplastic (glioblastoma multiforme)
0,543  0,004  Antiviral (Influenza)
0,549  0,012  Metabolic disease treatment
0,553  0,017  Cytotoxic
0,533  0,007  Wound healing agent
0,525  0,007  Antiviral (HIV)
0,517  0,005  Lipid peroxidase inhibitor
0,519  0,010  Antihypertriglyceridemic
0,523  0,017  NOS3 expression inhibitor
0,508  0,007  Melanin inhibitor
0,512  0,017  NOS2 expression inhibitor
0,509  0,019  Lipoprotein disorders treatment
0,491  0,005  Abortion inducer
0,483  0,014  UGT2B4 substrate
0,469  0,012  Antineoplastic (renal cancer)
0,454  0,004  Gastrin inhibitor
0,460  0,012  Antineoplastic (lymphocytic leukemia)
0,466  0,021  Antiprotozoal (Leishmania)
0,453  0,009  Contraceptive
0,473  0,040  Immunosuppressant
0,446  0,016  Antineoplastic (liver cancer)
0,447  0,030  Cardioprotectant
0,420  0,004  Cyclooxygenase 3 inhibitor
0,450  0,037  Immunostimulant
0,413  0,006  Antiviral (Hepatitis B)
0,425  0,021  Hypolipemic
0,406  0,004  Contraceptive female
0,439  0,039  Bone diseases treatment
0,419  0,024  Antipyretic
0,400  0,006  Insulin secretagoues
0,440  0,049  Atherosclerosis treatment
0,409  0,022  Antihypoxic
0,390  0,005  Cholesterol synthesis inhibitor
0,396  0,011  Antiviral (Hepatitis)
0,400  0,017  Sodium/bile acid cotransporter inhibitor
0,417  0,035  Antineoplastic (brain cancer)
0,399  0,020  Antiulcerative
0,420  0,044  Antithrombotic
0,387  0,015  Antiviral (Herpes)
0,387  0,021  Transcription factor STAT3 inhibitor
0,398  0,037  Antiosteoporotic
0,369  0,009  Interleukin 6 antagonist
0,416  0,060  Antipruritic, allergic
0,388  0,034  Sensitization
0,357  0,011  Protein kinase stimulant
0,376  0,035  Interleukin 2 agonist
0,354  0,017  UGT2B7 substrate
0,356  0,023  Antineoplastic (bladder cancer)
0,369  0,035  Carcinogenic
0,347  0,015  Prostate disorders treatment
0,358  0,041  Antineoplastic (non-small cell lung cancer)
0,395  0,079  Antibacterial
0,346  0,034  Angiogenesis stimulant
0,333  0,023  P-glycoprotein inhibitor
0,347  0,040  Proliferative diseases treatment
0,325  0,019  Prostatic (benign) hyperplasia treatment
0,309  0,013  Antiviral (Hepatitis C)
0,309  0,019  Lipocortins synthesis antagonist
0,317  0,032  UDP-glucuronosyltransferase substrate
0,346  0,062  Antifungal
0,305  0,030  Antihelmintic
0,278  0,005  Transcription factor NF kappa B stimulant
0,309  0,049  Cardiodepressant
0,284  0,025  Diuretic
0,305  0,046  Vasodilator
0,262  0,005  Inducible nitric-oxide synthase inhibitor
0,296  0,044  Antiparasitic
0,263  0,015  DNA polymerase I inhibitor
0,254  0,009  Anticataract
0,265  0,024  Skin whitener
0,298  0,057  Transcription factor STAT inhibitor
0,267  0,027  Antiacne
0,298  0,059  Renal disease treatment
0,247  0,009  Antiinfertility, female
0,292  0,054  Cardiovascular analeptic
0,250  0,013  UGT2B10 substrate
0,256  0,021  Acute respiratory distress syndrome (ARDS) treatment
0,308  0,073  Antipsoriatic
0,254  0,019  UGT2B9 substrate
0,258  0,024  Liver fibrosis treatment
0,246  0,013  Antihemorrhagic
0,261  0,031  Antipruritic, non-allergic
0,271  0,043  Platelet adhesion inhibitor
0,227  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,251  0,034  Insulin sensitizer
0,243  0,032  Antineoplastic (gastric cancer)
0,225  0,014  Arachidonic acid antagonist
0,272  0,065  Tumour necrosis factor alpha release inhibitor
0,241  0,035  Antihelmintic (Nematodes)
0,220  0,016  Microtubule formation inhibitor
0,273  0,069  Teratogen
0,212  0,011  HDL-cholesterol increasing
0,242  0,043  Neurotrophic factor enhancer
0,198  0,004  Lanosterol 14 alpha demethylase inhibitor
0,228  0,035  Hair growth stimulant
0,227  0,036  Antineoplastic (carcinoma)
0,193  0,005  Androgen agonist
0,223  0,035  UGT2B15 substrate
0,302  0,115  Antiobesity
0,190  0,008  Antiprotozoal (Toxoplasma)
0,184  0,006  Antiviral (Rhinovirus)
0,246  0,070  Free radical scavenger
0,176  0,003  Na+ K+ transporting ATPase inhibitor
0,182  0,016  Androgen antagonist
0,237  0,072  Antineoplastic (lymphoma)
0,278  0,113  CYP3A4 substrate
0,204  0,041  Antineoplastic (squamous cell carcinoma)
0,171  0,009  Anabolic
0,167  0,005  Glycine receptor antagonist
0,220  0,060  UGT1A1 substrate
0,238  0,079  Antineoplastic (sarcoma)
0,178  0,022  Choleretic
0,179  0,025  Expectorant
0,163  0,010  UGT2B11 substrate
0,173  0,027  Beta amyloid protein antagonist
0,175  0,032  Farnesoid X receptor antagonist
0,174  0,031  Adenylate cyclase stimulant
0,223  0,082  Embryotoxic
0,155  0,016  CC chemokine 6 receptor antagonist
0,300  0,168  Alzheimer's disease treatment
0,139  0,010  Bile acid receptor antagonist
0,143  0,016  Contraceptive male
0,154  0,028  Protease inhibitor
0,183  0,058  Antineoplastic (bone cancer)
0,123  0,004  Estrone sulfatase inhibitor
0,127  0,009  Estrogen receptor beta agonist
0,118  0,003  Cholesterol ester transfer protein antagonist
0,122  0,009  Transcription factor AP-1 inhibitor
0,117  0,007  Estrogen receptor alpha agonist
0,114  0,005  Heme oxygenase stimulant
0,162  0,056  Anesthetic
0,138  0,034  Antineoplastic antibiotic
0,148  0,043  Growth stimulant
0,142  0,039  Alcohol dehydrogenase substrate
0,107  0,006  RNA-directed RNA polymerase stimulant
0,114  0,015  Estrogen agonist
0,103  0,007  Diacylglycerol O-acyltransferase inhibitor
0,134  0,044  Shock treatment
0,143  0,053  Liver cirrhosis treatment
0,096  0,010  5-Alpha-reductase inhibitor
0,194  0,109  RNA-directed DNA polymerase inhibitor
0,098  0,014  Acetyl-CoA transferase inhibitor
0,205  0,122  UGT1A9 substrate
0,178  0,096  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,090  0,009  Lipocortins synthesis agonist
0,172  0,092  Sepsis treatment
0,142  0,064  Psychosexual dysfunction treatment
0,113  0,036  Actinic keratosis treatment
0,098  0,022  Aromatase inhibitor
0,185  0,109  UGT1A6 substrate
0,164  0,089  Diabetic nephropathy treatment
0,130  0,055  Interleukin 1b antagonist
0,112  0,036  SULT1E1 substrate
0,125  0,053  Caspase 3 inhibitor
0,099  0,028  CDC25A inhibitor
0,117  0,047  Sulfotransferase substrate
0,094  0,025  Glycine receptor agonist
0,221  0,153  Vasodilator, peripheral
0,070  0,004  Tubulin agonist
0,077  0,012  Aldosterone antagonist
0,134  0,072  Amylase inhibitor
0,067  0,006  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,074  0,014  Acetyl-CoA transferase 2 inhibitor
0,114  0,054  UGT2B1 substrate
0,066  0,008  Farnesoid X receptor agonist
0,127  0,070  Antihyperlipoproteinemic
0,117  0,061  Estrogen antagonist
0,092  0,037  Antiviral (Dengue virus)
0,094  0,040  3C-Like protease (SARS coronavirus) inhibitor
0,130  0,077  Antifungal enhancer
0,079  0,026  SULT2A1 substrate
0,082  0,031  Anticholelithogenic
0,076  0,026  Nitric oxide donor
0,085  0,035  Prostaglandin-E synthase inhibitor
0,153  0,105  Toxic, respiratory center
0,208  0,161  CTGF expression inhibitor
0,103  0,055  Nitric-oxide synthase inhibitor
0,056  0,009  Glucose-6-phosphate dehydrogenase inhibitor
0,060  0,014  Microtubule stabilization
0,176  0,133  Myocardial infarction treatment
0,067  0,024  Postcoital contraceptive
0,179  0,140  Interleukin agonist
0,133  0,096  Phospholipase A2 inhibitor
0,038  0,002  Telomerase stimulant
0,094  0,058  ABCA1 expression enhancer
0,089  0,054  Antileprosy
0,044  0,011  HMG CoA reductase inhibitor
0,036  0,006  Hedgehog signaling activator
0,050  0,021  Parathyroid hormone antagonist
0,033  0,005  Corticosteroid-like
0,094  0,068  Dementia treatment
0,092  0,066  Vascular dementia treatment
0,080  0,055  Chymotrypsin inhibitor
0,039  0,016  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,096  0,074  Topoisomerase I inhibitor
0,042  0,023  Cholesterol absorption inhibitor
0,148  0,130  Antirickettsial
0,055  0,037  Postmenopausal disorders treatment
0,099  0,081  SULT1A1 substrate
0,021  0,010  Progesterone agonist
0,230  0,220  Antiarthritic
0,028  0,019  1,3-Beta-glucan synthase inhibitor
0,097  0,089  Antitussive
0,010  0,002  Transcortin receptor antagonist
0,071  0,064  Narcotic antagonist
0,022  0,015  Vitamin D receptor antagonist
0,019  0,013  5-Alpha-reductase 2 inhibitor
0,054  0,049  Botulinum neurotoxin type A inhibitor
0,038  0,038  HIV-1 protease inhibitor

